Benjamin Huang, MD

Title(s)Assistant Professor, Pediatrics
SchoolSchool of Medicine
Address1450 Third St, #284
San Francisco CA 94158
ORCID ORCID Icon0000-0001-6996-0833 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, BerkeleyB.S.Electrical Engineering and Computer Sciences
    University of California, San FranciscoM.D.Medicine
    University of California, San FranciscoResidencyPediatrics
    University of California, San FranciscoFellowshipPediatric Hematology/Oncology
    Collapse Awards and Honors
    2001Eta Kappa Nu, Electrical Engineering and Computer Sciences Honor Society
    2006UC Berkeley Outstanding Graduate Student Instructor Award
    2009Alpha Omega Alpha, Medical Honor Society
    2010UCSF School of Medicine Essential Core Teaching Award
    2016St. Baldrick's Foundation Fellowship Award
    2017UCSF Bleecher Young Investigator Award
    2019Hyundai Hope on Wheels Scholar Award
    2020St. Baldrick’s Foundation Scholar Award
    2020Rally Foundation Career Development Award
    2022Hyundai Hope on Wheels Hope Scholar Award

    Collapse Overview 
    Collapse Overview
    Dr. Benjamin Huang is a physician-scientist whose research program focuses on mouse cancer modeling, molecular therapeutics, and functional genomics. He is a contributing member within the UCSF Helen Diller Family Comprehensive Cancer Center and several national committees; including the Children's Oncology Group (COG) Myeloid Committee, the COG AML Biology Steering Committee, and the Leukemia and Lymphoma Society (LLS) Pediatric Acute Leukemia (PedAL) Initiative Translational Science Team Committee.
    Collapse Websites

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. 5G2 mutant mice model loss of a commonly deleted segment of chromosome 7q22 in myeloid malignancies. Leukemia. 2024 Mar 05. Wong JC, Weinfurtner KM, Westover T, Kim J, Lebish EJ, Del Pilar Alzamora M, Huang BJ, Walsh M, Abdelhamed S, Ma J, Klco JM, Shannon K. PMID: 38443608.
      View in: PubMed   Mentions:    Fields:    
    2. Prognostic Impact of Co-occurring Mutations in FLT3-ITD Pediatric Acute Myeloid Leukemia. Blood Adv. 2024 Jan 31. Tarlock K, Gerbing RB, Ries RE, Smith JL, Leonti AR, Huang BJ, Kirkey DC, Robinson L, Peplinski JH, Lange B, Cooper TM, Gamis AS, Kolb EA, Aplenc R, Pollard JA, Meshinchi S. PMID: 38295280.
      View in: PubMed   Mentions:    Fields:    
    3. A new genomic framework to categorize pediatric acute myeloid leukemia. Nat Genet. 2024 Feb; 56(2):281-293. Umeda M, Ma J, Westover T, Ni Y, Song G, Maciaszek JL, Rusch M, Rahbarinia D, Foy S, Huang BJ, Walsh MP, Kumar P, Liu Y, Yang W, Fan Y, Wu G, Baker SD, Ma X, Wang L, Alonzo TA, Rubnitz JE, Pounds S, Klco JM. PMID: 38212634; PMCID: PMC10864188.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    4. Framework humanization optimizes potency of anti-CD72 nanobody CAR-T cells for B-cell malignancies. J Immunother Cancer. 2023 11 24; 11(11). Temple WC, Nix MA, Naik A, Izgutdina A, Huang BJ, Wicaksono G, Phojanakong P, Serrano JAC, Young EP, Ramos E, Salangsang F, Steri V, Xirenayi S, Hermiston M, Logan AC, Stieglitz E, Wiita AP. PMID: 38007238; PMCID: PMC10680002.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    5. Structural surfaceomics reveals an AML-specific conformation of integrin β2 as a CAR T cellular therapy target. Nat Cancer. 2023 Nov; 4(11):1592-1609. Mandal K, Wicaksono G, Yu C, Adams JJ, Hoopmann MR, Temple WC, Izgutdina A, Escobar BP, Gorelik M, Ihling CH, Nix MA, Naik A, Xie WH, Hübner J, Rollins LA, Reid SM, Ramos E, Kasap C, Steri V, Serrano JAC, Salangsang F, Phojanakong P, McMillan M, Gavallos V, Leavitt AD, Logan AC, Rooney CM, Eyquem J, Sinz A, Huang BJ, Stieglitz E, Smith CC, Moritz RL, Sidhu SS, Huang L, Wiita AP. PMID: 37904046; PMCID: PMC10663162.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    6. Hemophagocytic lymphohistiocytosis and clonally related T-cell malignancies in a pediatric patient. Pediatr Blood Cancer. 2023 Dec; 70(12):e30677. Meyer LK, Huang I, Huang BJ, Chung JH, Pawar A, Hermiston ML, Loh ML, Ohgami RS, Ruiz-Cordero R, Bhargava P, Marinoff AE. PMID: 37702960.
      View in: PubMed   Mentions:    Fields:    
    7. Structural and functional analyses of a germline KRAS T50I mutation provide insights into Raf activation. JCI Insight. 2023 09 08; 8(17). Chen PY, Huang BJ, Harris M, Boone C, Wang W, Carias H, Mesiona B, Mavrici D, Kohler AC, Bollag G, Zhang C, Zhang Y, Shannon K. PMID: 37681415; PMCID: PMC10544224.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    8. Opposing effects of KDM6A and JDP2 on glucocorticoid sensitivity in T-ALL. Blood Adv. 2023 07 25; 7(14):3479-3484. Levinson AL, Tjoa K, Huang B, Meyer LK, Kim MO, Brady SW, Zhang J, Shannon K, Wandler AM. PMID: 36897249; PMCID: PMC10362263.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    9. Melanoma in infants, caused by a gene fusion involving the anaplastic lymphoma kinase (ALK). Pigment Cell Melanoma Res. 2024 Jan; 37(1):6-14. Perkins IU, Tan SY, McCalmont TH, Chou PM, Mully TW, Gerami P, Pomerantz JH, Reyes-Múgica M, Balkin DM, Kruse LL, Huang B, Reichek JL, Gangopadhyay N, Chiosea S, Green JR, Chamlin SL, Frieden IJ, Bastian BC, Yeh I. PMID: 37475109.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Proposal of a new genomic framework for categorization of pediatric acute myeloid leukemia associated with prognosis. Res Sq. 2023 May 29. Umeda M, Ma J, Westover T, Ni Y, Song G, Maciaszek JL, Rusch M, Rahbarinia D, Foy S, Huang BJ, Walsh MP, Kumar P, Liu Y, Fan Y, Wu G, Baker SD, Ma X, Wang L, Rubnitz JE, Pounds S, Klco JM. PMID: 37398194; PMCID: PMC10312943.
      View in: PubMed   Mentions:
    11. NFIA-ETO2, TP53, and erythroid leukemogenesis. Blood. 2023 05 04; 141(18):2168-2170. Huang BJ, Shannon K. PMID: 37140954.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Venetoclax in combination with chemotherapy as treatment for pediatric advanced hematologic malignancies. Pediatr Blood Cancer. 2023 06; 70(6):e30335. Marinoff AE, Aaronson K, Agrawal AK, Braun BS, Golden C, Huang BJ, Michlitsch J, Southworth E, Thrall A, Vo KT, Stieglitz E. PMID: 37036306; PMCID: PMC10133180.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    13. Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication. Nat Commun. 2023 04 05; 14(1):1739. Liu Y, Klein J, Bajpai R, Dong L, Tran Q, Kolekar P, Smith JL, Ries RE, Huang BJ, Wang YC, Alonzo TA, Tian L, Mulder HL, Shaw TI, Ma J, Walsh MP, Song G, Westover T, Autry RJ, Gout AM, Wheeler DA, Wan S, Wu G, Yang JJ, Evans WE, Loh M, Easton J, Zhang J, Klco JM, Meshinchi S, Brown PA, Pruett-Miller SM, Ma X. PMID: 37019972; PMCID: PMC10076316.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    14. Machine learning classifier approaches for predicting response to RTK-type-III inhibitors demonstrate high accuracy using transcriptomic signatures and ex vivo data. Bioinform Adv. 2023; 3(1):vbad034. Ferrato MH, Marsh AG, Franke KR, Huang BJ, Kolb EA, DeRyckere D, Grahm DK, Chandrasekaran S, Crowgey EL. PMID: 37250111; PMCID: PMC10209528.
      View in: PubMed   Mentions:
    15. Pediatric Blood & Cancer. Clonally Related T-cell Malignancies and Hemophagocytic Lymphohistiocytosis in a Pediatric Patient. 2023; 70(S1):S33. Meyer L, Huang I, Huang BJ, Steen E, Chung JH, Pawar A, Hermiston M, Ohgami R, Ruiz-Cordero R, Bhargava P, Marinoff A.
    16. Long Noncoding RNA Expression Independently Predicts Outcome in Pediatric Acute Myeloid Leukemia. J Clin Oncol. 2023 06 01; 41(16):2949-2962. Farrar JE, Smith JL, Othus M, Huang BJ, Wang YC, Ries R, Hylkema T, Pogosova-Agadjanyan EL, Challa S, Leonti A, Shaw TI, Triche TJ, Gamis AS, Aplenc R, Kolb EA, Ma X, Stirewalt DL, Alonzo TA, Meshinchi S. PMID: 36795987; PMCID: PMC10414715.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    17. CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target. J Clin Invest. 2022 11 15; 132(22). Le Q, Hadland B, Smith JL, Leonti A, Huang BJ, Ries R, Hylkema TA, Castro S, Tang TT, McKay CN, Perkins L, Pardo L, Sarthy J, Beckman AK, Williams R, Idemmili R, Furlan S, Ishida T, Call L, Srivastava S, Loeb AM, Milano F, Imren S, Morris SM, Pakiam F, Olson JM, Loken MR, Brodersen L, Riddell SR, Tarlock K, Bernstein ID, Loeb KR, Meshinchi S. PMID: 36136600; PMCID: PMC9663156.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    18. Blood. American Society of Hematology. Transcriptome Analysis and Machine Learning Prioritize Therapeutic Strategies for High-Risk Pediatric AML Patients of the KMT2A-Fusion Subgroup. 2022; 140(S1):3385-3386. Obermayer A, Yao S, Smith JL, Ries RE, Wang Y-C, Farrar JE, Furlan SN, Triche R, Ma X, Huang BJ, Wang X, Meshinchi S, Shaw TI. View Publication.
    19. Blood. American Society of Hematology. Structural Surfaceomics Reveals an AML-Specific Conformation of Integrin-β2 As an Immunotherapeutic Target. 2022; 140(S1):867-868. Mandal K, Wicaksono G, Yu C, Adams JJ, Hoopmann MR, Temple WC, Escobar BP, Gorelik M, Ihling C, Nix MA, Naik A, Ramos E, Kasap C, Steri V, Serrano JC, Salangsang F, Phojanakong P, McMillan M, Gavallos V, Leavitt AD, Sinz A, Huang BJ, Stieglitz E, Smith C, Moritz RL, Sidhu SS, Huang L, Wiita AP. View Publication.
    20. Blood. American Society of Hematology. Expanding the High-Risk Definition for Children with Newly Diagnosed Acute Myeloid Leukemia. 2022; 140(S1):3393-3394. Lamble AJ, Ries RE, Alonzo TA, Wang Y-C, Farrar JE, Huang BJ, Kutny MA, Pollard JA, Aplenc R, Gamis AS, Kolb EA, Cooper TM, Meshinchi S. View Publication.
    21. Blood. American Society of Hematology. A Transcriptional Classifier Identifies Pediatric T-Cell Acute Lymphoblastic Leukemias at High Risk for End of Induction Minimal Residual Disease. 2022; 140(S1):1722-1723. Meyer LK, Roy RP, Pölönen P, Elsayed A, Huang BJ, Kimura S, Delgado-Martin C, Vincent TL, Ryan T, Wood BL, Chen Z, Liu Y, Zhang J, Horton TM, Loh ML, Devidas M, Raetz EA, Hayashi RJ, Winter SS, Dunsmore KP, Hunger SP, Pounds SB, Hermiston ML, Yang JJ, Mullighan CG, Teachey DT, Olshen AB. View Publication.
    22. Blood. American Society of Hematology. A Robust Long Non-Coding RNA Expression Classifier for Risk Stratification in Pediatric AML. 2022; 140(S1):9173-9174. Farrar JE, Smith JL, Othus M, Huang BJ, Wang Y-C, Ries RE, Hylkema TA, Pogosova-Agadjanyan EL, Challa S, Leonti AR, Shaw TI, Triche TJ, Gamis AS, Aplenc R, Kolb AE, Ma X, Stirewalt D, Alonzo TA, Meshinchi S. View Publication.
    23. Blood. American Society of Hematology. 140: 5973-5974. 15 Nov 2022. Opposing Effects of KDM6A and JDP2 on Glucocorticoid Sensitivity in T-ALL. 2022; 140(S1):5973-5974. Levinson A, Tjoa K, Huang BJ, Meyer LK, Brady SW, Zhang J, Shannon KM, Wandler A. View Publication.
    24. Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemia. Nat Commun. 2022 09 19; 13(1):5487. Huang BJ, Smith JL, Farrar JE, Wang YC, Umeda M, Ries RE, Leonti AR, Crowgey E, Furlan SN, Tarlock K, Armendariz M, Liu Y, Shaw TI, Wei L, Gerbing RB, Cooper TM, Gamis AS, Aplenc R, Kolb EA, Rubnitz J, Ma J, Klco JM, Ma X, Alonzo TA, Triche T, Meshinchi S. PMID: 36123353; PMCID: PMC9485122.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    25. Cancer Research. Longitudinal monitoring of pediatric acute myeloid leukemia using duplex sequencing of patient-specific panels reveals ultra-low frequency MRD that marks persistent carcinogenesis and complex clonal evolution. 2022; 82(S10):A009. Smith TH, Higgins JE, Lo FY, Hipp MJ, Valentine CC, Leonti AR, Ries RE, Meshinchi S, Huang BJ, Salk JJ. View Publication.
    26. Integrated Genomic Analysis Identifies UBTF Tandem Duplications as a Recurrent Lesion in Pediatric Acute Myeloid Leukemia. Blood Cancer Discov. 2022 05 05; 3(3):194-207. Umeda M, Ma J, Huang BJ, Hagiwara K, Westover T, Abdelhamed S, Barajas JM, Thomas ME, Walsh MP, Song G, Tian L, Liu Y, Chen X, Kolekar P, Tran Q, Foy SG, Maciaszek JL, Kleist AB, Leonti AR, Ju B, Easton J, Wu H, Valentine V, Valentine MB, Liu YC, Ries RE, Smith JL, Parganas E, Iacobucci I, Hiltenbrand R, Miller J, Myers JR, Rampersaud E, Rahbarinia D, Rusch M, Wu G, Inaba H, Wang YC, Alonzo TA, Downing JR, Mullighan CG, Pounds S, Babu MM, Zhang J, Rubnitz JE, Meshinchi S, Ma X, Klco JM. PMID: 35176137; PMCID: PMC9780084.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    27. Inhibition of the Sec61 translocon overcomes cytokine-induced glucocorticoid resistance in T-cell acute lymphoblastic leukaemia. Br J Haematol. 2022 07; 198(1):137-141. Meyer LK, Delgado-Martin C, Sharp PP, Huang BJ, McMinn D, Vincent TL, Ryan T, Horton TM, Wood BL, Teachey DT, Taunton J, Kirk CJ, Hermiston ML. PMID: 35434798; PMCID: PMC9322670.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    28. CBFB-MYH11 fusion transcripts distinguish acute myeloid leukemias with distinct molecular landscapes and outcomes. Blood Adv. 2021 12 14; 5(23):4963-4968. Huang BJ, Smith JL, Wang YC, Taghizadeh K, Leonti AR, Ries RE, Liu Y, Kolekar P, Tarlock K, Gerbing R, Crowgey E, Furlan SN, Shaw TI, Hagiwara K, Wei L, Cooper TM, Gamis AS, Aplenc R, Kolb EA, Farrar JE, Triche T, Alonzo TA, Ma X, Meshinchi S. PMID: 34547772; PMCID: PMC9153007.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    29. Blood. American Society of Hematology. Integrated Genomic Analysis Identifies UBTF Tandem Duplications As a Subtype-Defining Lesion in Pediatric Acute Myeloid Leukemia. 2021; 138(S2):4. Umeda M, Ma J, Huang BJ, Hagiwara K, Westover T, Abdelhamed S, Barajas JM, Thomas ME, Walsh MP, Song G, Tian L, Liu Y, Chen X, Kolekar P, Tran Q, Foy S, Maciaszek JL, Kleist AB, Leonti AR, Ju B, Easton J, Wu H, Valentine V, Valentine M, Liu Y-C, Ries RE, Smith JL, Parganas E, Iacobucci I, Hiltenbrand R, Miller J, Myers J, Rampersaud E, Rahbarinia D, Rusch M, Wu G, Inaba H, Wang Y-C, Alonzo TA, Downing JR, Mullighan CG, Pounds SB, Babu MM, Zhang J, Rubnitz JE, Meshinchi S, Ma X, Klco JM. View Publication.
    30. Blood. American Society of Hematology. Targeting FOLR1 in High-Risk CBF2AT3-GLIS2 AML with Stro-002 FOLR1-Directed Antibody-Drug Conjugate. 2021; 138(S1):209. Le Q, Smith JL, Tang TT, Castro S, Nourigat-Mckay C, Perkins L, Huang BJ, Ries RE, Leonti AR, Hylkema TA, Pardo L, Abrahams C, Bedard K, Molina A, Eidenschink Brodersen L, Loken MR, Meshinchi S. View Publication.
    31. Blood. American Society of Hematology. Integrated Transcriptomics and Proteomics Identifies Therapeutic Targets in Pediatric Acute Myeloid Leukemia. 2021; 138(S1):1296. Huang BJ, Smith JL, Shaw TI, Furlan SN, Ries RE, Leonti AR, Crowgey EL, Wei L, Farrar JE, Triche T, Ma X, Le Q, Meshinchi S. View Publication.
    32. Blood. American Society of Hematology. EZH2-Mediated MHC Class II Silencing Drives Immune Evasion in AML with t(16;21) FUS-ERG. 2021; 138(S1):374. Buteyn NJ, Burke CG, Smith JL, Ries RE, Leonti AR, Shaw TI, Huang BJ, Alonzo TA, Furlan SN, Farrar JE, Meshinchi S, Triche TJ. View Publication.
    33. Blood. American Society of Hematology. ETS Family Transcription Factor Fusions in Childhood AML: Distinct Expression Networks and Clinical Implications. 2021; 138(S1):2356. Smith JL, Ries RE, Wang Y-C, Leonti AR, Alonzo TA, Gamis AS, Aplenc R, Kolb AE, Huang BJ, Ma X, Shaw TI, Meshinchi S. View Publication.
    34. Journal of Clinical Oncology. Targeted gene expression classifier identifies pediatric T-cell acute lymphoblastic leukemia (T-ALL) patients at high risk for end induction minimal residual disease positivity. 2021; 39(S15):10002. Meyer LK, Roy R, Huang BJ, Delgado-Martin C, Vincent TL, Wood BL, Liu Y, Zhang J, Mullighan CG, Horton TM, Loh ML, Devidas M, Raetz EA, Hayashi RJ, Winter SS, Dunsmore KP, Hunger S, Teachey DT, Olshen AB Hermiston ML. View Publication.
    35. Leukemia Research. A Targeted Gene Expression Classifier Identifies Pediatric T-ALL Patient at High Risk for End Induction Minimal Residual Disease Positivity. 2021; 121:S34-S35. Meyer L, Roy RP, Huang BJ, Kimura S, Polonen P, Delgado-Martin C, Vincent T, Ryan T, Wood B, Liu Y, Zhang J, Mullighan C, Horton T, Loh M, Devidas M, Raetz E, Hayashi R, Winter S, Dunsmore K, Hunger S, Teachey D, Hermiston M, Olshen AB. View Publication.
    36. Single-cell DNA sequencing reveals complex mechanisms of resistance to quizartinib. Blood Adv. 2021 03 09; 5(5):1437-1441. Peretz CAC, McGary LHF, Kumar T, Jackson H, Jacob J, Durruthy-Durruthy R, Levis MJ, Perl A, Huang BJ, Smith CC. PMID: 33666651; PMCID: PMC7948271.
      View in: PubMed   Mentions: 11     Fields:    
    37. Blood. American Society of Hematology. Integrated Stem Cell Signature and Cytomolecular Risk Determination in Pediatric Acute Myeloid Leukemia. 2020; 136(S1):28-29. Huang BJ, Smith JL, Ries RE, Leonti AR, Crowgey EL, Furlan SN, Shaw T, Wei L, Wang Y-C, Gerbing RB, Alonzo TA, Cooper TM, Kolb EA, Ma X, Farrar JE, Triche TJ, Meshinchi S. View Publication.
    38. Blood. American Society of Hematology. Genome and Transcriptome Profiling of Monosomy 7 AML Defines Novel Risk and Therapeutic Cohorts. 2020; 136(S1):20-21. Ries RE, Triche TJ, Smith JL, Leonti AR, Alonzo TA, Farrar JE, Chen X, Liu Y, Shaw T, Huang BJ, Wang Y-C, Gerbing RB, Hirsch BA, Raimondi SC, Gamis AS, Aplenc R, Zhang J, Kolb EA, Ma X, Meshinchi S. View Publication.
    39. Blood. American Society of Hematology. Duplex Sequencing with Patient-Specific Hybrid Capture Panels Reveals Ultra-Low Frequency Measurable Residual Disease in Pediatric Acute Myeloid Leukemia. 2020; 136(S1):31-32. Higgins J, Lo FY, Hipp MJ, Valentine CC, Williams LN, Leonti AR, Ries RE, Radich JP, Meshinchi S, Huang BJ, Salk JJ. View Publication.
    40. Blood. American Society of Hematology. Co-Targeting BET Bromodomain Proteins and Aberrant Signaling in AML. 2020; 136(S1):5-6. Huang BJ, Wang X, Harris M, Wandler A, Hwang E, Burgess MR, Li Q, Severson P, Powell B, Kolb EA, Meshinchi S, Taylor BS, Bollag G, Shannon KM. View Publication.
    41. Nf1-Mutant Tumors Undergo Transcriptome and Kinome Remodeling after Inhibition of either mTOR or MEK. Mol Cancer Ther. 2020 11; 19(11):2382-2395. Pucciarelli D, Angus SP, Huang B, Zhang C, Nakaoka HJ, Krishnamurthi G, Bandyopadhyay S, Clapp DW, Shannon K, Johnson GL, Nakamura JL. PMID: 32847978; PMCID: PMC7907257.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    42. Genetic disruption of N-RasG12D palmitoylation perturbs hematopoiesis and prevents myeloid transformation in mice. Blood. 2020 05 14; 135(20):1772-1782. Zambetti NA, Firestone AJ, Remsberg JR, Huang BJ, Wong JC, Long AM, Predovic M, Suciu RM, Inguva A, Kogan SC, Haigis KM, Cravatt BF, Shannon K. PMID: 32219446; PMCID: PMC7225687.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    43. Loss of glucocorticoid receptor expression mediates in vivo dexamethasone resistance in T-cell acute lymphoblastic leukemia. Leukemia. 2020 08; 34(8):2025-2037. Wandler AM, Huang BJ, Craig JW, Hayes K, Yan H, Meyer LK, Scacchetti A, Monsalve G, Dail M, Li Q, Wong JC, Weinberg O, Hasserjian RP, Kogan SC, Jonsson P, Yamamoto K, Sampath D, Nakitandwe J, Downing JR, Zhang J, Aster JC, Taylor BS, Shannon K. PMID: 32066867; PMCID: PMC7440098.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimals
    44. Glucocorticoids paradoxically facilitate steroid resistance in T cell acute lymphoblastic leukemias and thymocytes. J Clin Invest. 2020 02 03; 130(2):863-876. Meyer LK, Huang BJ, Delgado-Martin C, Roy RP, Hechmer A, Wandler AM, Vincent TL, Fortina P, Olshen AB, Wood BL, Horton TM, Shannon KM, Teachey DT, Hermiston ML. PMID: 31687977; PMCID: PMC6994137.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    45. Convergent genetic aberrations in murine and human T lineage acute lymphoblastic leukemias. PLoS Genet. 2019 06; 15(6):e1008168. Huang BJ, Wandler AM, Meyer LK, Dail M, Daemen A, Sampath D, Li Q, Wang X, Wong JC, Nakitandwe J, Downing JR, Zhang J, Taylor BS, Shannon K. PMID: 31199785; PMCID: PMC6594654.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    46. Journal of Clinical Oncology. American Society of Clinical Oncology. Gene expression signature associated with in vitro dexamethasone resistance and post-induction minimal residual disease in pediatric T-cell acute lymphoblastic leukemia. 2019; 37:10033. Meyer LK, Delgado-Martin C, Roy R, Huang BJ, Vincent T, Olshen A, Wood BL, Liu Y, Zhang J, Mullighan CG, Horton TM, Loh ML, Devidas M, Raetz EA, Hayashi RJ, Winter S, Dunsmore KP, Hunger S, Teachey DT, Hermiston HL. View Publication.
    47. Blood. American Society of Hematology. Glucocorticoids Paradoxically Induce Intrinsic Steroid Resistance through a STAT5-Mediated Survival Mechanism in T-Cell Acute Lymphoblastic Leukemia. 2018; 132:913. Meyer LK, Huang BJ, Roy R, Hechmer A, Wandler A, Delgado-Martin C, Olshen AB, Horton TM, Teachey DT, Shannon KM, Hermiston ML. View Publication.
    48. British Journal of Haematology. Glucocorticoids paradoxically induce steroid resistance through a STAT5-mediated survival mechanism in T-cell acute lymphoblastic leukemia/lymphoma. 2018; 182:62-63. Meyer LK, Delgado-Martin C, Huang BJ, Wandler AM, Horton TM, Teachey DT, Shannon KM, Hermiston ML.
    49. JAK/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias. Leukemia. 2017 12; 31(12):2568-2576. Delgado-Martin C, Meyer LK, Huang BJ, Shimano KA, Zinter MS, Nguyen JV, Smith GA, Taunton J, Winter SS, Roderick JR, Kelliher MA, Horton TM, Wood BL, Teachey DT, Hermiston ML. PMID: 28484265; PMCID: PMC5729333.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansAnimalsCells
    50. KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in Cancer. Cell. 2017 02 23; 168(5):817-829.e15. Burgess MR, Hwang E, Mroue R, Bielski CM, Wandler AM, Huang BJ, Firestone AJ, Young A, Lacap JA, Crocker L, Asthana S, Davis EM, Xu J, Akagi K, Le Beau MM, Li Q, Haley B, Stokoe D, Sampath D, Taylor BS, Evangelista M, Shannon K. PMID: 28215705; PMCID: PMC5541948.
      View in: PubMed   Mentions: 100     Fields:    Translation:HumansAnimalsCells
    51. Blood. American Society of Hematology. Response and Resistance to Bromodomain Inhibition in AML Driven By Hyperactive Ras Signaling. 2016; 128:1654. Huang BJ, Hwang E, Wandler AM, Powell B, Bollag G, Shannon K. View Publication.
    52. Blood. American Society of Hematology. Resistant T-Cell Acute Lymphoblastic Leukemias That Emerge after In Vivo Treatment with Dexamethasone Frequently Down-Regulate Glucocorticoid Receptor Protein Expression. 2016; 128:753. Wandler AM, Huang B, Scacchetti A, Craig J, Yan H, Monsalve G, Li Q, Dail M, Wong JC, Nakitandwe J, Weinberg O, Hasserjian RP, Kogan SC, Sampath D, Downing JR, Yamamoto K, Taylor BS, Aster JC, Zhang J, Shannon K. View Publication.
    53. Blood. American Society of Hematology. Risk Factors for Graft Failure with Busulfan/Fludarabine-Based Conditioning in Children Undergoing Allogeneic Hematopoietic Cell Transplantation for Nonmalignant Disorders. 2014; 124:1155. Huang BJ, Dvorak CC, Wahlstrom J, Hwang J, Long-Boyle JR, Cowan MJ, Horn BN. View Publication.
    54. Mutant Ikzf1, KrasG12D, and Notch1 cooperate in T lineage leukemogenesis and modulate responses to targeted agents. Proc Natl Acad Sci U S A. 2010 Mar 16; 107(11):5106-11. Dail M, Li Q, McDaniel A, Wong J, Akagi K, Huang B, Kang HC, Kogan SC, Shokat K, Wolff L, Braun BS, Shannon K. PMID: 20194733; PMCID: PMC2841878.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansAnimalsCells
    55. Blood. American Society of Hematology. Expressing N-Ras(G12D) from the endogenous promoter induces myeloproliferative disease (MPD) and cooperates with retroviral insertional mutagenesis (RIM) to generate acute myeloid leukemia (AML). 2007; 110:482A-483A. Li Q, Haigis K, McDaniel A, Huang BJ, Miller M, Shieh A, Kogan S, Wolff L, Jacks T, Shannon K.
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    Work in Global Health Equity

    Offer Student Projects

    See more options in the Advanced Search tab

    Benjamin's Networks
    Concepts (127)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (43)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.